Hereditary Angioedema Therapeutic Market Poised for Double-Digit Growth at 16.79% CAGR to Reach US$ 14.19 Billion by 2029 Maximize Market Research unveils a comprehensive study on the Hereditary Angioedema Therapeutic Market. The market is expected to reach US$ 14.19 billion by 2029, propelled by a significant Compound Annual Growth Rate (CAGR) of 16.79%. Get PDF sample...